Abbott Laboratories (ABT) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Abbott Laboratories (ABT) Net Income towards Common Stockholders Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.54 Bn | 193.94 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 129.61 Bn | 126.14 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 120.10 Bn | 110.88 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 13.80% |
| 5 | Edwards Lifesciences | 52.52 Bn | 48.27 Bn | 1.35 Bn | -27.18% |
| 6 | Dexcom | 34.69 Bn | 32.75 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.68 Bn | 2.18 Bn | 14.80% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 73.85% |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn | 12.92% |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn | 30.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -47.84% |
| Mar 31, 2026 | -18.72% |
| Dec 31, 2025 | -80.76% |
| Sep 30, 2025 | -0.12% |
| Jun 30, 2025 | 36.64% |
| Mar 31, 2025 | 8.16% |
| Dec 31, 2024 | 478.98% |
| Sep 30, 2024 | 14.62% |
| Jun 30, 2024 | -5.31% |
| Mar 31, 2024 | -7.06% |
| Dec 31, 2023 | 54.31% |
| Sep 30, 2023 | 0.07% |
| Jun 30, 2023 | -31.86% |
| Mar 31, 2023 | -45.94% |
| Dec 31, 2022 | -47.85% |
| Sep 30, 2022 | -31.41% |
| Jun 30, 2022 | 70.44% |
| Mar 31, 2022 | 36.58% |
| Dec 31, 2021 | -7.90% |
| Sep 30, 2021 | 70.64% |